Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of June 22, 2025 • 3:00 AM ET

Date/Time Source News Release
05/06/2025 07:45 AM EDT PR Newswire Heron Therapeutics Announces First Quarter 2025 Financial Results and Highlights Recent Corporate Updates
05/06/2025 07:30 AM EDT PR Newswire Heron Therapeutics Announces Settlement with Mylan Related to CINVANTI® and APONVIE® Patent Litigations
04/28/2025 06:55 PM EDT PR Newswire Heron Therapeutics Announces Appointment of Mark Hensley as Chief Operating Officer
04/22/2025 04:05 PM EDT PR Newswire Heron Therapeutics to Report First Quarter 2025 Financial Results on Tuesday, May 6, 2025
02/27/2025 07:45 AM EST PR Newswire Heron Therapeutics Announces Fourth Quarter and Full-Year 2024 Financial Results and Highlights Recent Corporate Updates
02/13/2025 04:20 PM EST PR Newswire Heron Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results On Thursday, February 27, 2025
12/23/2024 04:05 PM EST PR Newswire Heron Therapeutics Announces Corporate Headquarters Relocation to Cary, North Carolina
12/03/2024 04:36 PM EST PR Newswire U.S. District Court Upholds Validity of CINVANTI® Patents
11/12/2024 07:55 AM EST PR Newswire Heron Therapeutics Announces Third Quarter 2024 Financial Results and Narrows Financial Guidance
11/04/2024 05:00 PM EST PR Newswire Heron Therapeutics Announces Appointment of Michael Kaseta to Board of Directors
Page

Additional News

As of June 22, 2025 • 3:00 AM ET

Date/Time Source News Release
05/09/2025 05:37 AM EDT SeekingAlpha Biotech Outperformance - Can't Take What's Already Earned
05/07/2025 03:38 PM EDT SeekingAlpha Heron Therapeutics: Q1 Paints A Potentially Rosy Picture For 2025
05/06/2025 11:38 AM EDT SeekingAlpha Heron Therapeutics, Inc. (HRTX) Q1 2025 Earnings Call Transcript
05/06/2025 10:15 AM EDT SeekingAlpha Heron settles patent dispute with Viatris over antiemetic agents
05/06/2025 09:30 AM EDT Zacks Compared to Estimates, Heron Therapeutics (HRTX) Q1 Earnings: A Look at Key Metrics
05/06/2025 08:55 AM EDT Zacks Heron Therapeutics (HRTX) Q1 Earnings and Revenues Top Estimates
05/06/2025 07:50 AM EDT SeekingAlpha Heron Therapeutics GAAP EPS of $0.01 beats by $0.02, revenue of $38.9M beats by $1.48M
05/06/2025 07:00 AM EDT US Earnings Reports Expected US Company Earnings on Tuesday, May 6th, 2025
05/06/2025 05:31 AM EDT US Earnings Reports Expected earnings - Heron Therapeutics Inc.
05/05/2025 06:00 PM EDT SeekingAlpha Here are the major earnings before the open tomorrow
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.